How are Pharmakogenetik Medicheck and menopause related?

The provided knowledge contexts contain no direct link between the Pharmakogenetik Medicheck and menopause. Pharmacogenetic tests analyze genetic variants affecting drug metabolism (e.g., CYP1A2, CYP2D6). Theoretically, such tests could be relevant in menopause because hormone replacement therapy (HRT) and other medications (e.g., antidepressants) are metabolized by these enzymes. However, the contexts lack specific studies or product details supporting this connection. Evidence is therefore classified as unclear. Consumers should be aware that the clinical validity of such tests for menopause is limited and no personalized HRT recommendations can be derived. Medical consultation remains essential.